UBX

Unity Biotechnology
UBX

Overview Fund Activity
Delisted

UBX was delisted on the 8th of July, 2025.

Back to rankings

55 hedge funds and large institutions have $258M invested in Unity Biotechnology in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
+13
Holders Change %
+30.95%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
21
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
1
BlackRock
New York
$30.1M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$11.8M
3
Capital World Investors
3
Capital World Investors
California
$23.8M
4
State Street
4
State Street
Massachusetts
$6.53M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$62.6M

Top Sellers

1
NTC
1
NF Trinity Capital
Hong Kong
$0
2
AG
2
Artal Group
Luxembourg
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$1.25M
4
Millennium Management
4
Millennium Management
New York
$0
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of Montreal
51
Bank of Montreal
Ontario, Canada
$6K +$5.31K +31 +775%
GI
52
Gradient Investments
Minnesota
$2K +$2K +13 New
RE
53
RBC Europe
United Kingdom
$1.63K – – –
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$1.46K -$1.3K -8 -47%
NTC
55
NF Trinity Capital
Hong Kong
– -$9.91M -60,806 Closed
AG
56
Artal Group
Luxembourg
– -$815K -5,000 Closed
Millennium Management
57
Millennium Management
New York
– -$666K -4,090 Closed
D.E. Shaw & Co
58
D.E. Shaw & Co
New York
– -$183K -1,122 Closed
TRCT
59
Tower Research Capital (TRC)
New York
– -$16K -99 Closed
US Bancorp
60
US Bancorp
Minnesota
– -$15K -92 Closed
CCA
61
Catalyst Capital Advisors
New York
– -$8K -48 Closed
1 2
3